Oral

Day 1
17 Lug 2019
ORAL

003 – Macrophages Regulate Schwann Cell Maturation after Nerve Injury

Jo Anne Stratton (1)
Hotchkiss Brain Institute, 3330 Hospital drive NW, University of Calgary, HMRB 403b Foothills Campus, Calgary, Canada (1) - Hotchkiss Brain Institute, University of Calgary, Calgary, Canada (2)
ORAL

015 – Rescuing over-activated microglia by acetaminophen treatment restores cognitive performance in the Dp(16) mouse model of Down Syndrome

Bruno Pinto (1, 2)
BIO@SNS, Scuola Normale Superiore, Piazza dei Cavalieri 7, 56126. Pisa (1) - Local Micro-environment and Brain Development Laboratory, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova (2)
ORAL

002 – The neuroprotective effects of calpastatin on axonal integrity in a murine model of Guillian-Barre_ Syndrome

Hannah Bialic (1)
University of Glasgow, Institute of Infection, Immunity, and Inflammation, Glasgow, United Kingdom (1)
ORAL

014 – A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis

Erik Nutma (1)
Department of Pathology, Amsterdam UMC, Location VUmc, The Netherlands (1)
ORAL

005 – Fatty acid desaturation impairs the reparative features of phagocytes in the central nervous system

Elien Grajchen (1#)
Department of Neuroimmunology and Biochemistry, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium (1)
Day 2
18 Lug 2019
ORAL

029 – PD-L1 and PD-L2 expression in blood immune cells and cerebrospinal fluid extracellular vesicles in Multiple Sclerosis. ThereÕs room for novel therapeutic approaches.

Tommaso Croese (1)
Institute of Experimental Neurology (INSPE), Clinical Neuroimmunology Unit, Milan, Italy (1)
ORAL

007 – A bioinformatics approach to study microglial morphology and surveillance in CNS diseases

Ilias Roufagalas (1)
Hellenic Pasteur Institute, Laboratory Of Molecular Genetics, Athens, Greece (1)
ORAL

038 – Soluble TNF inhibits phagocytosis of myelin debris by mouse macrophage and microglia, and remyelination of demyelinated lesions

Athina Boutou (1)
Hellenic Pasteur Institute, Labortatory of Molecular Genetics, Department of Immunology, Athens, Greece (1)
ORAL

032 – Development of drug-screening platform with murine and human neurons for multiple sclerosis (MS) to identify compounds with a neuroprotective potential and assess disease-specific dysfunctions.

Svetlana Bezukladova (1)
San Raffaele Scientific Institute, Division of Neuroscience - INSPE - Institute of Experimental Neurology, Neuroimmunology Unit, Milano, Italy (1)
ORAL

047 – RNA-transcriptome guided optimization of in vitro culture conditions for adult primary microglia

Raissa Timmerman (1)
Alternatives Unit, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288 GJ Rijswijk, The Netherlands (1)
Day 3
19 Lug 2019
ORAL

009 – The role of autoreactive antibodies in initiation and propagation of central nervous system demyelinating disorders

Marie Freier (1)
Department of Neuropathology, University Medical Centre, Georg August University Gšttingen (1)
ORAL

028 – Transcriptional analysis of peripheral monocytes upon fingolimod treatment in Relapsing Remitting Multiple Sclerosis patients

Giacomo Sferruzza (1)
San Raffaele Scientific Institute, Neurology, Milano, Italy (1)
ORAL

010 – Chitinase 3-like 1 as a biomarker of multiple sclerosis progression

Laura Cubas-Nuñez (1+)
Multiple Sclerosis and Neural Regeneration Research Group. Health Research Institute La Fe. Avda. Fernando Abril Martorell, 102. 46026 Valncia (1) - Central Neuroimmmunology Unit. Hospital Universitari i Politcnic La Fe. Avda. Fernando Abril Martorell, 106. 46026 Valncia (2) - Department of Neuroimmunology (Center for Brain Research). Spitalgasse 4 Vienna (Austria) (3) - + Equal contribution
ORAL

018 – TGFB1-mediated gliosis in multiple sclerosis spinal cords is favored by the physiological expression of regionalization homeobox genes and the age-dependent decline in androgen receptor ligands

Serge Nataf (1)
University Claude Bernard Lyon-1, CarMeN Laboratory, INSERM 1060, INRA 1397, INSA Lyon, Bank of Tissues and Cells, Hospices Civils de Lyon, Lyon, France (1)
ORAL

013 – Muscular Involvement in Lewis Rats with Experimental Neuromyelitis Optica

Magdalini Nigritinou (1)
Center of Brain Research, Neuroimmunology Department, Medical University of Vienna, Vienna, Austria (1)